ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands
Lawsuit filed against Lonza, the Dutch manufacturer of the world's first CRISPR-based genome editing therapy, CASGEVY Second European action following UK litigation, enforcing ToolGen's rights to fundamental CRISPR-Cas9 RNP technology
IIPLA News DeskMonday, May 4, 2026